Literature DB >> 24318732

Methods of repair for obstetric anal sphincter injury.

Ruwan J Fernando1, Abdul H Sultan, Christine Kettle, Ranee Thakar.   

Abstract

BACKGROUND: Anal sphincter injury during childbirth - obstetric anal sphincter injuries (OASIS) - are associated with significant maternal morbidity including perineal pain, dyspareunia (painful sexual intercourse) and anal incontinence, which can lead to psychological and physical sequelae. Many women do not seek medical attention because of embarrassment. The two recognised methods for the repair of damaged external anal sphincter (EAS) are end-to-end (approximation) repair and overlap repair.
OBJECTIVES: To compare the effectiveness of overlap repair versus end-to-end repair following OASIS in reducing subsequent anal incontinence, perineal pain, dyspareunia and improving quality of life. SEARCH
METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 September 2013) and reference lists of retrieved studies. SELECTION CRITERIA: Randomised controlled trials comparing different techniques of immediate primary repair of EAS following OASIS. DATA COLLECTION AND ANALYSIS: Trial quality was assessed independently by all authors. MAIN
RESULTS: Six eligible trials, of variable quality, involving 588 women, were included. There was considerable heterogeneity in the outcome measures, time points and reported results. Meta-analyses showed that there was no statistically significant difference in perineal pain (risk ratio (RR) 0.08, 95% confidence interval (CI) 0.00 to 1.45, one trial, 52 women), dyspareunia (average RR 0.77, 95% CI 0.48 to 1.24, two trials, 151 women), flatus incontinence (average RR 1.14, 95% CI 0.58 to 2.23, three trials, 256 women) between the two repair techniques at 12 months. However, it showed a statistically significant lower incidence of faecal urgency (RR 0.12, 95% CI 0.02 to 0.86, one trial, 52 women), and lower anal incontinence score (standardised mean difference (SMD) -0.70, 95% CI -1.26 to -0.14, one trial, 52 women) in the overlap group. The overlap technique was also associated with a statistically significant lower risk of deterioration of anal incontinence symptoms over 12 months (RR 0.26, 95% CI 0.09 to 0.79, one trial, 41 women). There was no significant difference in quality of life. At 36 months follow-up, there was no difference in flatus incontinence (average RR 1.12, 95% CI 0.63 to 1.99, one trial, 68 women) or faecal incontinence (average RR 1.01, 95% CI 0.34 to 2.98, one trial, 68 women). AUTHORS'
CONCLUSIONS: The data available show that at one-year follow-up, immediate primary overlap repair of the external anal sphincter compared with immediate primary end-to-end repair appears to be associated with lower risks of developing faecal urgency and anal incontinence symptoms. At the end of 36 months there appears to be no difference in flatus or faecal incontinence between the two techniques. However, since this evidence is based on only two small trials, more research evidence is needed in order to confirm or refute these findings.

Entities:  

Mesh:

Year:  2013        PMID: 24318732     DOI: 10.1002/14651858.CD002866.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  23 in total

1.  Management of 3rd and 4th Degree Perineal Tears after Vaginal Birth. German Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/079, October 2014).

Authors:  T Aigmueller; W Bader; K Beilecke; K Elenskaia; A Frudinger; E Hanzal; H Helmer; H Huemer; M van der Kleyn; D Koelle; S Kropshofer; J Pfeiffer; C Reisenauer; A Tammaa; K Tamussino; W Umek
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-02       Impact factor: 2.915

Review 2.  Fistulotomy or fistulectomy and primary sphincteroplasty for anal fistula (FIPS): a systematic review.

Authors:  C Ratto; F Litta; L Donisi; A Parello
Journal:  Tech Coloproctol       Date:  2015-06-11       Impact factor: 3.781

Review 3.  Use of endoanal ultrasound for reducing the risk of complications related to anal sphincter injury after vaginal birth.

Authors:  Kate A Walsh; Rosalie M Grivell
Journal:  Cochrane Database Syst Rev       Date:  2015-10-29

Review 4.  Antenatal maternal education for improving postnatal perineal healing for women who have birthed in a hospital setting.

Authors:  Sonia M O'Kelly; Zena Eh Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-12-04

5.  Fecal Incontinence: Epidemiology, Impact, and Treatment.

Authors:  Katarzyna Bochenska; Anne-Marie Boller
Journal:  Clin Colon Rectal Surg       Date:  2016-09

6.  A retrospective review of 1495 patients with obstetric anal sphincter injuries referred for assessment of function and endoanal ultrasonography.

Authors:  G P Thomas; L E Gould; F Casunuran; D A Kumar
Journal:  Int J Colorectal Dis       Date:  2017-07-07       Impact factor: 2.571

7.  Prevention and Management of Severe Obstetric Anal Sphincter Injuries (OASIs): a National Survey of Nurse- Midwives.

Authors:  Sindi Diko; Maryam Guiahi; Amy Nacht; Kathleen A Connell; Shane Reeves; Beth A Bailey; K Joseph Hurt
Journal:  Int Urogynecol J       Date:  2019-03-15       Impact factor: 2.894

8.  Prevention of pelvic floor disorders: international urogynecological association research and development committee opinion.

Authors:  Tony Bazi; Satoru Takahashi; Sharif Ismail; Kari Bø; Alejandra M Ruiz-Zapata; Jonathan Duckett; Dorothy Kammerer-Doak
Journal:  Int Urogynecol J       Date:  2016-03-12       Impact factor: 2.894

Review 9.  Techniques for Repair of Obstetric Anal Sphincter Injuries.

Authors:  Melanie R Meister; Joshua I Rosenbloom; Jerry L Lowder; Alison G Cahill
Journal:  Obstet Gynecol Surv       Date:  2018-01       Impact factor: 2.347

10.  Impact of electronic and blended learning programs for manual perineal support on incidence of obstetric anal sphincter injuries: a prospective interventional study.

Authors:  Hadil Ali-Masri; Sahar Hassan; Erik Fosse; Kaled M Zimmo; Mohammed Zimmo; Khaled M K Ismail; Åse Vikanes; Katariina Laine
Journal:  BMC Med Educ       Date:  2018-11-12       Impact factor: 2.463

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.